Economic impact of using maternal plasma cell-free DNA testing to guide further workup in recurrent pregnancy loss.
Siyang PengSucheta BhattAntoni BorrellYuval YaronPublished in: Prenatal diagnosis (2021)
Our study showed that inclusion of cfDNA testing is a cost-effective approach to guide RPL workup.